Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil with Chemotherapy in Advanced NSCLC
NCT00752115Phase 3Completed
- Sponsor
- Hamamatsu University School of Medicine
- Start
- Feb 2007
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in non-small cell lung cancer (NSCLC) comparing Sildenafil Arm with Placebo Arm (2 arms). Primary endpoint: Progression-Free Survival at 3 years. Started Feb 2007; status: completed.
02
Drugs
sildenafil
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00752115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00752115.